412 related articles for article (PubMed ID: 17606426)
21. [Thyroid transcription factor-1 in pulmonary cytology].
Smojver-Jezek S; Vrabec-Branica B; Juros Z; Boras Z; Cucević B; Mazuranić I
Acta Med Croatica; 2008 Oct; 62(4):373-8. PubMed ID: 19205414
[TBL] [Abstract][Full Text] [Related]
22. CK7/CK20 Double-Negative Pulmonary Enteric Adenocarcinoma With Histopathological Evaluation of Transformation Zone Between Enteric Adenocarcinoma and Conventional Pulmonary Adenocarcinoma.
Miyaoka M; Hatanaka K; Iwazaki M; Nakamura N
Int J Surg Pathol; 2018 Aug; 26(5):464-468. PubMed ID: 29411669
[TBL] [Abstract][Full Text] [Related]
23. Primary seminal vesicle carcinoma: an immunohistochemical analysis of four cases.
Ormsby AH; Haskell R; Jones D; Goldblum JR
Mod Pathol; 2000 Jan; 13(1):46-51. PubMed ID: 10658909
[TBL] [Abstract][Full Text] [Related]
24. Villin, cytokeratin 7, and cytokeratin 20 expression in pulmonary adenocarcinoma with ultrastructural evidence of microvilli with rootlets.
Tan J; Sidhu G; Greco MA; Ballard H; Wieczorek R
Hum Pathol; 1998 Apr; 29(4):390-6. PubMed ID: 9563790
[TBL] [Abstract][Full Text] [Related]
25. Pulmonary intestinal-type adenocarcinoma.
Maeda R; Isowa N; Onuma H; Miura H
Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):349-51. PubMed ID: 18184677
[TBL] [Abstract][Full Text] [Related]
26. Thyroid transcription factor-1 and cytokeratins 7 and 20 in pulmonary and breast carcinoma.
Harlamert HA; Mira J; Bejarano PA; Baughman RP; Miller MA; Whitsett JA; Yassin R
Acta Cytol; 1998; 42(6):1382-8. PubMed ID: 9850647
[TBL] [Abstract][Full Text] [Related]
27. The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin.
Hecht JL; Pinkus JL; Weinstein LJ; Pinkus GS
Am J Clin Pathol; 2001 Oct; 116(4):483-8. PubMed ID: 11601132
[TBL] [Abstract][Full Text] [Related]
28. Positive immunostaining for thyroid transcription factor-1 in primary and metastatic colonic adenocarcinoma: a note of caution.
Penman D; Downie I; Roberts F
J Clin Pathol; 2006 Jun; 59(6):663-4. PubMed ID: 16731609
[TBL] [Abstract][Full Text] [Related]
29. Metastatic thoracic lymph node carcinoma of unknown origin on which we performed two kinds of immunohistochemical examinations.
Yoshino N; Yamauchi S; Hino M; Ohaki Y; Koizumi K; Shimizu K
Ann Thorac Cardiovasc Surg; 2006 Aug; 12(4):283-6. PubMed ID: 16977301
[TBL] [Abstract][Full Text] [Related]
30. Immunophenotypic characterization of 225 prostate adenocarcinomas with intermediate or high Gleason scores.
Goldstein NS
Am J Clin Pathol; 2002 Mar; 117(3):471-7. PubMed ID: 11888088
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach.
Lagendijk JH; Mullink H; van Diest PJ; Meijer GA; Meijer CJ
J Clin Pathol; 1999 Apr; 52(4):283-90. PubMed ID: 10474521
[TBL] [Abstract][Full Text] [Related]
32. Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases.
Jones TD; Kernek KM; Yang XJ; Lopez-Beltran A; MacLennan GT; Eble JN; Lin H; Pan CX; Tretiakova M; Baldridge LA; Cheng L
Hum Pathol; 2005 Jul; 36(7):718-23. PubMed ID: 16084939
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemistry of Cytokeratin 7, Cytokeratin 20 and Thyroid Transcription Factor-1 in Metastatic Carcinoma of Cervical Lymph Node Biopsy for Identification of Pulmonary Origin in Rajavithi Hospital.
Kuakpaetoon T
J Med Assoc Thai; 2017 Feb; 100 Suppl 1():S172-6. PubMed ID: 29927559
[TBL] [Abstract][Full Text] [Related]
34. Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases.
Zamecnik J; Kodet R
Virchows Arch; 2002 Apr; 440(4):353-61. PubMed ID: 11956814
[TBL] [Abstract][Full Text] [Related]
35. Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma.
Shah RN; Badve S; Papreddy K; Schindler S; Laskin WB; Yeldandi AV
Hum Pathol; 2002 Sep; 33(9):915-20. PubMed ID: 12378517
[TBL] [Abstract][Full Text] [Related]
36. The value of cytokeratins 20 and 7 in discriminating metastatic adenocarcinomas from pleural mesotheliomas.
Tot T
Cancer; 2001 Nov; 92(10):2727-32. PubMed ID: 11745209
[TBL] [Abstract][Full Text] [Related]
37. Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma.
Park SY; Kim BH; Kim JH; Lee S; Kang GH
Arch Pathol Lab Med; 2007 Oct; 131(10):1561-7. PubMed ID: 17922593
[TBL] [Abstract][Full Text] [Related]
38. The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody.
Bayrak R; Haltas H; Yenidunya S
Diagn Pathol; 2012 Jan; 7():9. PubMed ID: 22268990
[TBL] [Abstract][Full Text] [Related]
39. Modified classification for adenocarcinoma of the gastro-oesophageal junction.
Shearer CJ; Going JJ; Neilson LJ; Stuart RC
ANZ J Surg; 2007 Jul; 77(7):544-9. PubMed ID: 17610690
[TBL] [Abstract][Full Text] [Related]
40. Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers.
Wu M; Szporn AH; Zhang D; Wasserman P; Gan L; Miller L; Burstein DE
Diagn Cytopathol; 2005 Oct; 33(4):223-7. PubMed ID: 16138374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
